Represented PreferCare LLC in the sale of 70% of its equity to private equity firm American Health Partners.

Represented CoreMedica Laboratories, Inc. in its sale to a private equity fund for $10 million in cash and stock.

Represented owner of Small Factory Innovations, Inc. in sale to Central Reach LLC private equity fund.

Represented U.S. subsidiary of U.K. company in the sale of the U.K. parent to a U.K. private equity fund.

Represented a non-US investor in the negotiation and $2 million investment in Kanbrick Holdings, L.P, a private equity fund.

Represented Hivemind Investment Fund in its $3 million purchase of Series A4 Preferred Stock of Sannpa Limited d/b/a Fnatics, Inc.

Represented a U.S. mobile phone service distributor in the sale of its Convertible Preferred Stock to an investor equal to 10% of our clients’ fully diluted equity.

Represented CoreMedica Laboratories Inc., known for its innovation in micro and dried blood collection and analysis, with respect to the offering of its Convertible Promissory Notes.

Represented CoreMedica Laboratories Inc. in connection with its $3 MM offering of Series A-1 Preferred Stocks.

Represented Scientific Intake Co. LLC in the offering of $8 MM of its Series C Preferred Units.

Represented investor in $3 million purchase of Convertible Notes and Warrants of Platform Imaging, Inc.

Represented Azimuth Quartzy Fund LLC in connection with the secondary sale of Series A Interests in the Fund.

Represented an emerging growth imaging company in the $1.3 MM offering of its Convertible Promissory Notes.

Represented the investment group in the purchase of $5MM of Series A Preferred Units of a fast casual restaurant company.

Represented a major venture capital fund in the successful secondary sale of units by JP Morgan to Goldman Sachs Management entity.

Represented Easton Capital Partners, LP in the secondary sale of certain Series A Interests in the Fund.

Represented Shimojani, LLC in its offering and sale of Series A, B and C Units in the biotech company.

Represented Concord Health Partners in the negotiation and purchase of Series B Preferred Stock in the $12 million offering by Post Acute Analytics, Inc.

Represented Cognome, Inc. (an AI healthcare platform) in its formation and spin out from a major hospital system, including licensing of technology and preparation for preferred stock offering.

Represented investors in formation of Neuroinversa, LLC which is an early stage company developing diagnosis and treatment for autism.

Represented Burmester & Vogel Ltd. (a company specializing in developing and licensing software for the maritime industry) in its corporate formation, fundraising, and build out of artificial intelligence platform for SaaS licensing to shipping companies and traders. Advised them in the sale of Series A Preferred Stock and acquisition of a German marine technology company.

Represented eMedia LLC in the repurchase of 50% of its equity from one of the founders and restructuring of the ownership of the Company to include several senior officers.

Represented Nautilus Funding Solutions, LLC, a middle market debt fund in its organization as a Series LLC and fundraising as well as filing as an Exempt Investment Advisor.

Represented Luna Collective, LLC in its organization and fundraising to establish an angel investment fund to invest in Central American companies.

Represented Sparkle Capital Limited in its $4.3 million litigation financing provided to a U.S. borrower and the security agreements in connection with such financing.

Represented CoreMedica Laboratories Inc. in its acquisition of two Swiss biotech companies.

Represented one of the General Partners in the negotiation and restructuring of the Distribution Agreement among the General Partners of Odyssey Partners, LP.

Represented a major venture capital fund in the successful secondary sale of units by JP Morgan to Goldman Sachs Management entity.

Represented Arrowhead Capital LLC regarding the formation of a Series of Special Purpose Vehicles in the Cayman Islands for offshore investments.